17th Sep 2020 15:04
Ap19
FORM 8.3 - Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 15 September 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,208,689 | 1.71% | 466,648 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
587,000 | 0.46% | 388,524 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
2,795,689 | 2.17% | 855,172 | 0.66% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 4 | 206.3400 USD |
| Purchase | 30 | 207.4600 USD |
| Purchase | 100 | 206.4400 USD |
| Purchase | 100 | 205.9600 USD |
| Purchase | 146 | 206.5224 USD |
| Purchase | 152 | 207.6798 USD |
| Purchase | 170 | 207.4905 USD |
| Purchase | 200 | 207.7012 USD |
| Purchase | 208 | 207.5521 USD |
| Purchase | 297 | 207.6137 USD |
| Purchase | 300 | 206.9416 USD |
| Purchase | 300 | 207.9400 USD |
| Purchase | 400 | 207.3050 USD |
| Purchase | 420 | 207.8602 USD |
| Purchase | 425 | 207.4477 USD |
| Purchase | 970 | 207.7312 USD |
| Purchase | 1,497 | 206.2984 USD |
| Purchase | 2,190 | 207.2173 USD |
| Purchase | 2,400 | 207.8293 USD |
| Purchase | 3,701 | 206.2500 USD |
| Purchase | 4,003 | 207.1525 USD |
| Purchase | 7,759 | 206.7429 USD |
| Purchase | 8,827 | 207.2995 USD |
| Purchase | 10,339 | 206.9060 USD |
| Purchase | 99,800 | 207.1234 USD |
| Sale | 1 | 207.9900 USD |
| Sale | 2 | 208.0150 USD |
| Sale | 2 | 207.8550 USD |
| Sale | 4 | 206.3400 USD |
| Sale | 4 | 207.9512 USD |
| Sale | 5 | 207.5900 USD |
| Sale | 5 | 207.8320 USD |
| Sale | 9 | 207.8444 USD |
| Sale | 10 | 207.4440 USD |
| Sale | 11 | 206.6500 USD |
| Sale | 17 | 207.4750 USD |
| Sale | 21 | 207.7573 USD |
| Sale | 29 | 207.4700 USD |
| Sale | 76 | 207.6798 USD |
| Sale | 100 | 207.9500 USD |
| Sale | 100 | 206.9700 USD |
| Sale | 200 | 207.2350 USD |
| Sale | 285 | 206.7756 USD |
| Sale | 300 | 208.0441 USD |
| Sale | 303 | 207.0021 USD |
| Sale | 350 | 206.3671 USD |
| Sale | 500 | 207.7810 USD |
| Sale | 516 | 206.3383 USD |
| Sale | 927 | 207.3341 USD |
| Sale | 1,400 | 206.8357 USD |
| Sale | 1,497 | 206.2984 USD |
| Sale | 1,900 | 207.2255 USD |
| Sale | 1,900 | 207.8421 USD |
| Sale | 2,187 | 206.1725 USD |
| Sale | 3,807 | 206.2500 USD |
| Sale | 3,900 | 207.1641 USD |
| Sale | 4,212 | 206.6353 USD |
| Sale | 4,235 | 207.0072 USD |
| Sale | 4,277 | 206.9685 USD |
| Sale | 5,142 | 207.5274 USD |
| Sale | 5,200 | 207.0489 USD |
| Sale | 7,738 | 207.2026 USD |
| Sale | 7,876 | 207.3083 USD |
| Sale | 7,954 | 207.1910 USD |
| Sale | 8,286 | 207.5730 USD |
| Sale | 9,039 | 206.8860 USD |
| Sale | 10,569 | 206.8754 USD |
| Sale | 44,842 | 207.0666 USD |
| Sale | 44,842 | 207.0666 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 17 Sep 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200917005592/en/
Copyright Business Wire 2020
Related Shares:
Barclays